GALT Galectin Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$3.90
· of 52w range
· above low
· to high
$2.0352w low
$7.0352w high
Market Cap (MRQ)
$259M
P/E
-8.1
EPS
$-0.48
your badges
52W Range
$2–$7
Analyst Rating
BUY
Price Target
$11
P/E
-8.1
ROE
25.0%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
GALT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.90
Market Cap (MRQ)
$259M
P/E
-8.1
EPS
$-0.48
ROE
25.0%
52W Range
$2–$7
GALT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| March 23, 2012 | 1-for-6 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.482020-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | GALT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -8.15Y avg ≈-4.2 | ≈-4.2 | · | · | |
| P/B (MRQ) | -1.95Y avg ≈32.9 | ≈32.9 | · | · | |
| Price / Cash Flow | -10.75Y avg ≈-5.4 | ≈-5.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | GALT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -166.6%5Y avg ≈-135.2% | ≈-135.2% | -52.1% | Weak | |
| ROE | 25.0%5Y avg ≈-123.7% | ≈-123.7% | -58.3% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | GALT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.15Y avg ≈2.6 | ≈2.6 | 4.5 | Low liquidity | |
| Quick Ratio | 2.25Y avg ≈2.4 | ≈2.4 | 2.4 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-5.9%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $-0.14 | $-0.09 | -52.5% |
| March 31, 2026 | May 15, 2026 | $-0.08 | $-0.06 | -30.7% |
| Dec. 31, 2025 | $-0.08 | $-0.10 | 21.6% | |
| Sept. 30, 2025 | $-0.13 | $-0.11 | -15.9% | |
| June 30, 2025 | $-0.12 | $-0.16 | 26.5% | |
| March 31, 2025 | $-0.15 | $-0.20 | 26.5% | |
| Dec. 31, 2024 | $-0.19 | $-0.16 | -16.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $37M | $32M | $32M | $24M | $18M | $7M | $6M | $12M | $15M | $13M | $8M | |
| SG&A Expense | $6M | $6M | $6M | $7M | $6M | $5M | $6M | $7M | $5M | $6M | $7M | $7M | |
| Operating Expenses | $20M | $42M | $38M | $38M | $30M | $23M | $13M | $14M | $16M | $21M | $20M | $15M | |
| Operating Income | $-20M | $-42M | $-38M | $-38M | $-30M | $-23M | $-13M | $-14M | $-16M | $-21M | $-20M | $-15M | |
| Interest Expense | · | · | $3M | $1M | $489.0K | $87.0K | $87.0K | $336.0K | $12.0K | · | · | · | |
| Interest Income | $126.0K | $338.0K | $230.0K | $52.0K | $3.0K | $66.0K | $231.0K | $38.0K | $24.0K | $45.0K | $52.0K | $42.0K | |
| Other Non-op | $-11M | $-5M | $-3M | $-424.0K | $-348.0K | $-21.0K | $144.0K | $-298.0K | $12.0K | $45.0K | $52.0K | $-358.0K | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-31M | $-47M | $-41M | $-39M | $-31M | $-23M | $-13M | $-14M | $-16M | $-21M | $-20M | $-16M | |
| EPS (Basic) | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 | $-0.41 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 | $-0.41 | · | · | · | · | · | · | |
| Shares (Basic) | 63,903,000 | 62,309,000 | 60,159,000 | 59,391,000 | 58,527,000 | 57,029,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 63,903,000 | 62,309,000 | 60,159,000 | 59,391,000 | 58,527,000 | 57,029,000 | · | · | · | · | · | · | |
| EBITDA | $-20M | · | $-38M | $-38M | $-30M | $-23M | $-13M | $-14M | · | · | · | $-15M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $15M | $26M | $19M | $40M | $27M | $47M | $8M | $3M | $15M | $26M | $29M | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $2M | $2M | $729.0K | $579.0K | $766.0K | $432.0K | $554.0K | $533.0K | |
| Current Assets | $19M | $17M | $28M | $21M | $42M | $29M | $48M | $9M | $4M | $16M | $26M | $30M | |
| PP&E (Net) | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $1.0K | |
| PP&E (Gross) | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | |
| Accum. Depreciation | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $73.0K | |
| Intangibles | · | · | · | · | · | · | · | $0 | $0 | $1.0K | $8.0K | $15.0K | |
| Other Non-current Assets | $96.0K | $243.0K | $490.0K | $733.0K | $7.0K | $135.0K | $258.0K | $174.0K | $342.0K | · | · | · | |
| Total Assets | $20M | $17M | $28M | $21M | $42M | $30M | $48M | $9M | $4M | $16M | $26M | $30M | |
| Accounts Payable | $3M | $6M | $6M | $4M | $2M | $1M | $2M | $297.0K | $608.0K | $910.0K | $448.0K | $906.0K | |
| Accrued Liabilities | $5M | $8M | $9M | $9M | $7M | $4M | $1M | $2M | $2M | $3M | $845.0K | $729.0K | |
| Current Liabilities | $8M | $35M | $16M | $13M | $9M | $5M | $3M | $2M | $3M | $4M | $1M | $2M | |
| Capital Leases | · | · | $20.0K | $66.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $0 | · | $20.0K | $66.0K | $0 | $8.0K | $52.0K | $0 | · | · | · | $0 | |
| Total Liabilities | $146M | $121M | $88M | $53M | $39M | $5M | $3M | $2M | $3M | $4M | $1M | $2M | |
| Common Stock | $65.0K | $62.0K | $61.0K | $59.0K | $59.0K | $56.0K | $56.0K | $41.0K | $36.0K | $33.0K | $28.0K | $22.0K | |
| Paid-in Capital | $304M | $296M | $292M | $275M | $271M | $262M | $260M | $194M | $173M | $167M | $158M | $140M | |
| Retained Earnings | $-433M | $-402M | $-354M | $-310M | $-271M | $-240M | $-216M | $-196M | $-181M | $-164M | $-140M | $-119M | |
| Stockholders' Equity | $-128M | $-105M | $-62M | $-34M | $893.0K | $22M | $44M | $5M | $-530.0K | $10M | $18M | $21M | |
| Liabilities + Equity | $20M | $17M | $28M | $21M | $42M | $30M | $48M | $9M | $4M | $16M | $26M | $30M | |
| Shares Outstanding | 65,201,995 | 63,157,235 | 61,852,914 | 59,426,005 | 59,341,305 | 57,077,055 | 56,894,642 | 41,190,905 | 35,789,388 | 32,912,942 | 28,825,033 | 22,277,283 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | $7.0K | $7.0K | $10.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $1M | $2M | $3M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $1.0K | $7.0K | $7.0K | $8.0K | |
| Other Non-cash | · | · | · | · | · | · | · | $-724.0K | · | · | · | $-718.0K | |
| Operating Cash Flow | $-24M | $-42M | $-33M | $-31M | $-24M | $-21M | $-11M | $-10M | $-16M | $-16M | $-17M | $-12M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | · | · | |
| Stock Issued | $3M | $0 | · | $0 | $7M | $263.0K | $50M | $15M | $4M | $6M | $14M | $29M | |
| Net Stock Activity | $3M | · | · | $0 | $7M | $263.0K | $50M | $15M | · | · | · | $29M | |
| Financing Cash Flow | $26M | $31M | $40M | $10M | $37M | $263.0K | $50M | $15M | $4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $5M | $-12M | $-10M | $-3M | $19M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -166.6% | · | -166.0% | -122.9% | -85.5% | -60.1% | -46.3% | -211.1% | · | · | · | -78.2% | |
| ROE | 25.0% | · | 71.7% | 133.8% | -725.2% | -89.8% | -29.0% | -223.8% | · | · | · | -139.2% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | 1.8 | 1.6 | 4.6 | 5.5 | 17.1 | 4.2 | · | · | · | 17.4 | |
| Quick Ratio | 2.2 | · | 1.6 | 1.4 | 4.4 | 5.0 | 16.8 | 3.9 | · | · | · | 17.1 | |
| Interest Coverage | · | · | -13.6 | -37.1 | -61.7 | -269.5 | -154.5 | -40.5 | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.96 | · | $-1.00 | $-0.57 | $0.01 | $0.39 | $0.77 | $0.13 | · | · | · | $0.95 | |
| Cash Flow / Share | $-0.37 | · | $-0.55 | $-0.52 | $-0.42 | · | · | · | · | · | · | · | |
| Cash / Share | $0.27 | · | $0.41 | $0.31 | $0.67 | $0.48 | $0.83 | $0.20 | · | · | · | $1.31 | |
| EPS (TTM) | $-0.48 | · | $-0.74 | $-0.65 | $-0.52 | $-0.41 | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-31M | · | $-41M | $-39M | $-31M | $-23M | $-13M | $-14M | $-16M | $-21M | $-20M | $-16M | |
| Market Cap | $271M | · | $103M | $67M | $123M | $128M | $163M | $141M | · | · | · | $77M | |
| P/E | -8.7 | · | -2.2 | -1.7 | -4.0 | -5.5 | · | · | · | · | · | · | |
| P/B | -2.1 | · | -1.7 | -2.0 | 137.6 | 5.7 | 3.7 | 27.3 | · | · | · | 3.6 | |
| P / Tangible Book | · | · | · | · | 137.6 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -11.4 | · | -3.1 | -2.2 | -5.1 | -6.2 | -15.0 | -13.9 | · | · | · | -6.2 | |
| Earnings Yield | -11.5% | · | -44.6% | -57.5% | -25.1% | -18.3% | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $2M | $2M | $3M | $3M | $6M | $11M | $8M | $10M | $8M | $8M | $8M | $7M | $9M | $9M | $7M | |
| SG&A Expense | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $4M | $3M | $4M | $5M | $8M | $12M | $9M | $11M | $10M | $10M | $9M | $9M | $10M | $11M | $8M | |
| Operating Income | $-4M | $-4M | $-3M | $-4M | $-5M | $-8M | $-12M | $-9M | $-11M | $-10M | $-10M | $-9M | $-9M | $-10M | $-11M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | $847.0K | $835.0K | $650.0K | $460.0K | $308.0K | $269.0K | |
| Interest Income | $28.0K | $36.0K | $26.0K | $39.0K | $26.0K | $35.0K | $85.0K | $93.0K | $80.0K | $80.0K | $74.0K | $62.0K | $50.0K | $44.0K | $30.0K | $18.0K | |
| Other Non-op | $-5M | $-969.0K | $-2M | $-4M | $-3M | $-2M | $461.0K | $-2M | $-1M | $-2M | $-436.0K | $-1M | $-111.0K | $-1M | $-1.0K | $-475.0K | |
| Net Income | $-9M | $-5M | $-6M | $-8M | $-8M | $-10M | $-12M | $-11M | $-12M | $-11M | $-10M | $-10M | $-9M | $-12M | $-11M | $-9M | |
| EPS (Basic) | $-0.14 | $-0.08 | $-0.08 | $-0.13 | $-0.12 | $-0.15 | $-0.19 | $-0.18 | $-0.20 | $-0.19 | $-0.16 | $-0.24 | $-0.15 | $-0.19 | $-0.18 | $-0.14 | |
| EPS (Diluted) | $-0.14 | $-0.08 | $-0.08 | $-0.13 | $-0.12 | $-0.15 | $-0.19 | $-0.18 | $-0.20 | $-0.19 | $-0.16 | $-0.24 | $-0.15 | $-0.19 | $-0.18 | $-0.14 | |
| Shares (Basic) | 65,875,000 | 65,782,000 | · | 64,205,000 | 63,447,000 | 63,204,000 | · | 62,278,000 | 62,233,000 | 61,976,000 | · | 59,704,000 | 59,582,000 | 59,480,000 | · | 59,396,000 | |
| Shares (Diluted) | 65,875,000 | 65,782,000 | · | 64,205,000 | 63,447,000 | 63,204,000 | · | 62,278,000 | 62,233,000 | 61,976,000 | · | 59,704,000 | 59,582,000 | 59,480,000 | · | 59,396,000 | |
| EBITDA | $-4M | $-4M | · | $-4M | $-5M | $-8M | · | $-9M | $-11M | $-10M | · | $-9M | $-9M | $-10M | · | $-8M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $14M | $18M | $12M | $14M | $7M | $15M | $27M | $26M | $24M | $26M | $20M | $18M | $18M | $19M | $16M | |
| Prepaid Expense | $1M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | |
| Current Assets | $15M | $16M | $19M | $13M | $15M | $9M | $17M | $29M | $27M | $25M | $28M | $22M | $19M | $20M | $21M | $17M | |
| PP&E (Net) | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | |
| PP&E (Gross) | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | |
| Accum. Depreciation | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | |
| Other Non-current Assets | $167.0K | $68.0K | $96.0K | $136.0K | $175.0K | $243.0K | $243.0K | $306.0K | $368.0K | $430.0K | $490.0K | $552.0K | $613.0K | $673.0K | $733.0K | $793.0K | |
| Total Assets | $15M | $16M | $20M | $13M | $16M | $10M | $17M | $29M | $28M | $26M | $28M | $22M | $20M | $20M | $21M | $18M | |
| Accounts Payable | $4M | $3M | $3M | $5M | $6M | $7M | $6M | $3M | $4M | $4M | $6M | $3M | $2M | $3M | $4M | $2M | |
| Accrued Liabilities | $4M | $4M | $5M | $5M | $5M | $7M | $8M | $12M | $11M | $9M | $9M | $8M | $8M | $9M | $9M | $7M | |
| Current Liabilities | $152M | $7M | $8M | $136M | $11M | $111M | $35M | $25M | $15M | $13M | $16M | $11M | $10M | $12M | $13M | $10M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | $7.0K | $20.0K | $32.0K | $43.0K | $55.0K | $66.0K | $77.0K | |
| Other Non-current Liabilities | $59.0K | · | · | · | · | · | · | $0 | $0 | $7.0K | $20.0K | $32.0K | $44.0K | $55.0K | $66.0K | $77.0K | |
| Total Liabilities | $152M | $146M | $146M | $136M | $133M | $122M | $121M | $121M | $110M | $97M | $88M | $73M | $71M | $63M | $53M | $40M | |
| Common Stock | $66.0K | $65.0K | $65.0K | $64.0K | $63.0K | $63.0K | $62.0K | $62.0K | $62.0K | $61.0K | $61.0K | $61.0K | $59.0K | $59.0K | $59.0K | $59.0K | |
| Paid-in Capital | $308M | $305M | $304M | $301M | $299M | $297M | $296M | $295M | $294M | $292M | $292M | $291M | $277M | $276M | $275M | $274M | |
| Retained Earnings | $-447M | $-438M | $-433M | $-427M | $-419M | $-411M | $-402M | $-390M | $-378M | $-366M | $-354M | $-344M | $-330M | $-321M | $-310M | $-299M | |
| Stockholders' Equity | $-139M | $-132M | $-128M | $-125M | $-119M | $-114M | $-105M | $-94M | $-84M | $-73M | $-62M | $-53M | $-53M | $-44M | $-34M | $-24M | |
| Liabilities + Equity | $15M | $16M | $20M | $13M | $16M | $10M | $17M | $29M | $28M | $26M | $28M | $22M | $20M | $20M | $21M | $18M | |
| Shares Outstanding | 66,311,910 | 65,856,898 | 65,201,995 | 64,472,792 | 64,060,262 | 63,291,585 | 63,157,235 | 62,308,075 | 62,278,125 | 62,148,134 | 61,852,914 | 61,848,657 | 59,582,253 | 59,582,253 | 59,426,005 | 59,426,005 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $963.0K | $686.0K | $195.0K | $496.0K | $500.0K | $468.0K | $590.0K | $515.0K | $738.0K | $604.0K | $497.0K | $586.0K | $516.0K | $662.0K | $681.0K | $681.0K | |
| Operating Cash Flow | $-2M | $-4M | $-6M | $-4M | $-7M | $-8M | $-13M | $-9M | $-8M | $-12M | $-5M | $-8M | $-10M | $-11M | $-7M | $-8M | |
| Stock Issued | · | · | $1M | $853.0K | · | · | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $2M | $257.0K | $12M | $1M | $13M | $0 | $851.0K | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $0 |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -59.9% | -39.9% | · | -39.1% | -34.8% | -54.4% | · | -43.9% | -51.8% | -49.8% | · | -52.0% | -39.6% | -42.8% | · | -30.7% | |
| ROE | 7.1% | 4.1% | · | 7.5% | 7.4% | 10.3% | · | 15.3% | 18.1% | 19.6% | · | 27.2% | 26.1% | 44.1% | · | 104.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 2.1 | · | 0.1 | 1.4 | 0.1 | · | 1.1 | 1.9 | 2.0 | · | 2.1 | 2.0 | 1.7 | · | 1.8 | |
| Quick Ratio | 0.1 | 1.9 | · | 0.1 | 1.3 | 0.1 | · | 1.1 | 1.8 | 1.9 | · | 1.9 | 1.8 | 1.5 | · | 1.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -9.2 | · | -11.0 | -13.9 | -22.5 | · | -30.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-2.09 | $-2.00 | · | $-1.94 | $-1.86 | $-1.80 | · | $-1.51 | $-1.35 | $-1.17 | · | $-0.85 | $-0.89 | $-0.74 | · | $-0.40 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.12 | · | · | · | $-0.20 | · | · | · | $-0.18 | · | · | |
| Cash / Share | $0.20 | $0.21 | · | $0.18 | $0.21 | $0.12 | · | $0.43 | $0.41 | $0.38 | · | $0.33 | $0.30 | $0.30 | · | $0.27 | |
| EPS (TTM) | $-0.43 | $-0.41 | · | $-0.59 | $-0.64 | $-0.72 | · | $-0.73 | $-0.79 | $-0.74 | · | $-0.76 | $-0.66 | $-0.67 | · | $-0.59 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-28M | $-26M | · | $-37M | $-40M | $-45M | · | $-45M | $-44M | $-41M | · | $-42M | $-40M | $-40M | · | $-35M | |
| Market Cap | $308M | $184M | · | $273M | $135M | $77M | · | $171M | $141M | $149M | · | $119M | $86M | $125M | · | $97M | |
| P/E | -10.8 | -6.8 | · | -7.2 | -3.3 | -1.7 | · | -3.8 | -2.9 | -3.2 | · | -2.5 | -2.2 | -3.1 | · | -2.8 | |
| P/B | -2.2 | -1.4 | · | -2.2 | -1.1 | -0.7 | · | -1.8 | -1.7 | -2.0 | · | -2.3 | -1.6 | -2.8 | · | -4.0 | |
| P / Cash Flow | · | -47.5 | · | · | · | -10.0 | · | · | · | -12.3 | · | · | · | -11.6 | · | · | |
| Earnings Yield | -9.3% | -14.7% | · | -13.9% | -30.3% | -59.0% | · | -26.6% | -35.0% | -31.0% | · | -39.6% | -45.8% | -31.9% | · | -36.2% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-31M | $-47M | $-41M | $-39M | $-31M |
| Diluted EPS | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | 1.8 | 1.6 | 4.6 |
| Quick Ratio | 2.2 | · | 1.6 | 1.4 | 4.4 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 109 filers · $87.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
109
Value held
$87.3M
New positions
21
Exited positions
18
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 21 (-2 vs prior Q) | 18 (+5 vs prior Q) | 33 (+2 vs prior Q) | 25 (0 vs prior Q) | +1.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $13,865,957 | 2,988,353 | 15.88% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $10,059,822 | 2,168,065 | 11.52% | Shares |
| VANGUARD GROUP INC | $9,521,608 | 2,288,848 | 10.91% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $6,072,509 | 1,308,394 | 6.96% | Shares |
| OSAIC HOLDINGS, INC. | $5,585,280 | 1,203,725 | 6.40% | Shares |
| MARSHALL WACE, LLP | $3,855,888 | 831,010 | 4.42% | Shares |
| GREAT POINT PARTNERS LLC | $3,712,000 | 800,000 | 4.25% | Call option |
| Wealthspire Advisors, LLC | $3,349,097 | 721,788 | 3.84% | Shares |
| STATE STREET CORP | $2,634,495 | 567,779 | 3.02% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $1,889,000 | 407,113 | 2.16% | Shares |
| NORTHERN TRUST CORP | $1,793,569 | 386,545 | 2.05% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,700,449 | 366,476 | 1.95% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,520,834 | 327,766 | 1.74% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,476,657 | 318,245 | 1.69% | Shares |
| LPL Financial LLC | $1,324,163 | 285,380 | 1.52% | Shares |
| Geneos Wealth Management Inc. | $1,115,581 | 240,427 | 1.28% | Shares |
| UBS Group AG | $1,017,641 | 219,319 | 1.17% | Shares |
| CITADEL ADVISORS LLC | $981,824 | 211,600 | 1.12% | Put option |
| RETIREMENT GUYS FORMULA LLC | $979,286 | 211,053 | 1.12% | Shares |
| CITADEL ADVISORS LLC | $921,973 | 198,701 | 1.06% | Shares |
| Sovran Advisors, LLC | $874,610 | 257,997 | 1.00% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $822,194 | 177,197 | 0.94% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $779,056 | 167,900 | 0.89% | Shares |
| DEBUSSY CAPITAL MANAGEMENT LP | $721,449 | 258,584 | 0.83% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $700,640 | 151,000 | 0.80% | Call option |
| BLAIR WILLIAM & CO/IL | $692,673 | 149,283 | 0.79% | Shares |
| CITADEL ADVISORS LLC | $597,168 | 128,700 | 0.68% | Call option |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $540,207 | 116,424 | 0.62% | Shares |
| Bank of New York Mellon Corp | $490,644 | 105,742 | 0.56% | Shares |
| HighTower Advisors, LLC | $436,740 | 94,125 | 0.50% | Shares |
| MORGAN STANLEY | $433,724 | 93,475 | 0.50% | Shares |
| SIMPLEX TRADING, LLC | $386,284 | 83,251 | 0.44% | Shares |
| GOLDMAN SACHS GROUP INC | $345,931 | 74,554 | 0.40% | Shares |
| TRUIST FINANCIAL CORP | $315,520 | 68,000 | 0.36% | Shares |
| Nuveen, LLC | $295,614 | 63,710 | 0.34% | Shares |
| BANK OF AMERICA CORP /DE/ | $267,798 | 57,715 | 0.31% | Shares |
| RHUMBLINE ADVISERS | $224,257 | 48,332 | 0.26% | Shares |
| DEUTSCHE BANK AG\ | $219,950 | 47,403 | 0.25% | Shares |
| HORIZON KINETICS ASSET MANAGEMENT LLC | $217,932 | 46,968 | 0.25% | Shares |
| WELLS FARGO & COMPANY/MN | $216,646 | 46,691 | 0.25% | Shares |
| SYNOVUS FINANCIAL CORP | $203,280 | 48,000 | 0.23% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $201,112 | 43,343 | 0.23% | Shares |
| Sanctuary Advisors, LLC | $193,627 | 41,730 | 0.22% | Shares |
| Pinnacle Financial Partners, Inc. | $193,256 | 41,650 | 0.22% | Shares |
| Caption Management, LLC | $185,600 | 40,000 | 0.21% | Call option |
| JPMORGAN CHASE & CO | $184,825 | 37,188 | 0.21% | Shares |
| MILLENNIUM MANAGEMENT LLC | $166,404 | 35,863 | 0.19% | Shares |
| Pekin Hardy Strauss, Inc. | $139,200 | 30,000 | 0.16% | Shares |
| MetLife Investment Management, LLC | $133,980 | 28,875 | 0.15% | Shares |
| Invesco Ltd. | $119,211 | 25,692 | 0.14% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Richard E. Uihlein ×3 filings | Aug. 4, 2026 | 49.30% | Amendment | Passive investment | SEC |
| 10X Fund, L.P., 10X Capital Management, LLC, James C. Czirr ×15 filings | Dec. 1, 2023 | · | Initial filing | Passive investment | SEC |
| Rod D. Martin ×9 filings | May 18, 2010 | · | Initial filing | · | SEC |
| James C. Czirr ×12 filings | May 17, 2010 | · | Initial filing | · | SEC |
| 10X Fund, L.P. 10X Capital Management, LLC | March 24, 2009 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 41 insiders · 12 officers · 28 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Joel Lewis | President and CEO | Jan. 16, 2026 A | 832,592 | 0 | 10 | $-620,880 |
| Peter G Traber | President & CEO | June 13, 2018 M | 107,333 | 0 | 0 | $0 |
| David Platt | Chairman & CEO | Oct. 8, 2008 P | 6,000 | 0 | 0 | $0 |
| Jack W Callicutt | Chief Financial Officer | Jan. 16, 2026 A | 7,614 | 0 | 20 | $-944,312 |
| Thomas Mcgauley | Chief Financial Officer | June 19, 2013 A | 10,000 | 0 | 0 | $0 |
| Anthony Don Squeglia | Chief Financial Officer | Feb. 1, 2010 A | · | 0 | 0 | $0 |
| Carl Laurence Lueders | Chief Financial Officer | March 8, 2007 A | · | 0 | 0 | $0 |
| David A Christopher | FORMER CFO & TREASURER | Oct. 14, 2003 M | 17,729 | 0 | 0 | $0 |
| Maureen Foley | Chief Operating Officer | Feb. 1, 2010 A | 5,000 | 0 | 0 | $0 |
| Khurram Jamil | Chief Medical Officer | July 14, 2026 M | 0 | 0 | 17 | $-1,435,942 |
| Pol F Boudes | Chief Medical Officer | Jan. 24, 2024 A | · | 0 | 0 | $0 |
| Eliezer Zomer | Ex. VP, Mfg. & Product Dev. | April 21, 2009 A | · | 0 | 0 | $0 |
| Richard E Uihlein | Director | July 31, 2026 M | 44,713,843 | 0 | 0 | $0 |
| Harold H. Shlevin | Director | June 29, 2026 M | 6,500 | 0 | 14 | $-1,555,866 |
| Henry Brem | Director | March 12, 2026 A | · | 0 | 0 | $0 |
| Kary Eldred | Director | Feb. 6, 2026 P | 65,682 | 3 | 0 | $6,032 |
| Richard A. Zordani Jr. | Director | Jan. 16, 2026 A | 42,083 | 0 | 0 | $0 |
| Elissa J. Schwartz | Director | Jan. 16, 2026 A | 1,000 | 0 | 0 | $0 |
| Kevin D Freeman | Director | Jan. 16, 2026 A | 55,269 | 3 | 0 | $58,575 |
| Gilbert S Omenn | Director | Jan. 16, 2026 A | 66,769 | 0 | 0 | $0 |
| Gilbert F Amelio | Director | Jan. 16, 2026 A | 60,614 | 0 | 0 | $0 |
| Benjamin Carson SR | Director | Jan. 16, 2026 A | · | 0 | 0 | $0 |
| Marc Rubin | Director | Jan. 23, 2025 A | 13,581 | 0 | 0 | $0 |
| Stephen Shulman | Director | Jan. 16, 2019 A | · | 0 | 0 | $0 |
| Theodore Daniel Zucconi | Director | April 16, 2018 M | 1,083 | 0 | 0 | $0 |
| John F Mauldin | Director | Dec. 15, 2016 A | 42,669 | 0 | 0 | $0 |
| Arthur Greenberg | Director | Dec. 15, 2016 A | 109,445 | 0 | 0 | $0 |
| Steven Prelack | Director | Dec. 15, 2016 A | 107,189 | 0 | 0 | $0 |
| Herman Paul Pressler | Director | April 8, 2015 D | 36,767 | 0 | 0 | $0 |
| Rod D Martin | Director | April 8, 2015 D | 202,089 | 0 | 0 | $0 |
| Jerald K Rome | Director | March 28, 2013 A | 22,058 | 0 | 0 | $0 |
| Sydney Colin Neill | Director | June 28, 2011 A | · | 0 | 0 | $0 |
| Mildred S Christian | Director | Feb. 25, 2009 A | 27,500 | 0 | 0 | $0 |
| Henry Jemil Esber | Director | Feb. 8, 2009 A | · | 0 | 0 | $0 |
| James Theophile Gourzis | Director | Feb. 8, 2009 A | 2,000 | 0 | 0 | $0 |
| Burton C Firtel | Director | March 8, 2007 A | 129,000 | 0 | 0 | $0 |
| David H Smith | Director | March 8, 2007 A | 63,500 | 0 | 0 | $0 |
| Edgar Ben-Josef | Director | March 9, 2006 A | · | 0 | 0 | $0 |
| James C Czirr | 10% owner | June 6, 2025 M | 1,045,541 | 0 | 0 | $0 |
| 10X Fund, L.P. | 10% owner | July 27, 2022 S | 6,168,940 | 0 | 0 | $0 |
| Dale H Conaway | · | Feb. 8, 2009 A | 22,806 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 11 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.04% | 164,297 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 275,017 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 35,584 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 309,874 SH | Sept. 11, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 1,042,597 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.00% | 22,888 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 595,153 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,521,443 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 12,968 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 4,197 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 155,156 SH | Sept. 11, 2026 | Daily |
GALT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$11.00
+182.1%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-02Mean target $11.00 +182.1%
Low$11.00
Mean$11.00
High$11.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| GALT | $271M | -8.7 | · | · | 25.0% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| KYTX | $568M | -2.6 | · | · | -77.4% | · |
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026